Change in ambulatory systolic blood pressure (A and B) and diastolic blood pressure (C and D) from baseline to week 8 in patient subgroups based on nocturnal blood pressure dipping status (dipper: A and C, nondipper: B and D).
diabetes
DIABETES
Data are least‐squares mean change±standard error (repeated‐measures ANCOVA model). Daytime: 6 Sacubitril/valsartan was significantly more effective than olmesartan at lowering 24‐hour ambulatory SBP in all patient subgroups, except for those with diabetes (Figure All treatments reduced SBP and DBP throughout the 24‐hour dosing interval (Figure 